Abstract:
Described herein are methods of diagnosing and/or classifying heatiness, a syndrome recognized in traditional Chinese Medicine, comprising assessing a patient by checking for selected symptoms, and assigning a score to the patient based on the symptoms exhibited. The invention further provides methods of treatment and the use of oral care compositions to treat heatiness.
Abstract:
La presente invención se refiere a una combinación de los polifenoles resveratrol, quercetina y catequina en una relación molar de aproximadamente1:1:2 o bien aproximadamente 1:1:5 que presenta un poder antioxidante sinérgico. Esta combinación de polifenoles es adecuada para ser incorporada en todo tipo de formulaciones farmacéuticas, cosméticas, alimenticias o veterinarias y puede utilizarse en la prevención y tratamiento de patologías o estados fisiológicos susceptibles de ser tratados con sustancias antioxidantes y captadoras de radicales libres.
Abstract:
A method of treating the skin and accelerating its natural anti-aging and wound-healing processes by using photorejuvenation at a specified total light flux at a specified range of wavelengths from a hand-held light source in combination with the topical ingredients including extracts. Some extracts may be panax ginseng, camellia sinensis, and/or gynostemma pentaphyllum, to effect superior transdermal penetration and intra-cellular delivery, effecting greater bioavailability and bioutilization of some other anti-aging topicals.
Abstract:
Improved compositions, delivery systems and methods for promoting healthy sexual function. The compositions include a portion or extract of the plant Sophora flavescens, such as sophoflavescenol. The compositions also include Vitex agnus-castus extract, and/or one or more of lipoic acid, L-Arginine, folic acid, trimethylglycine, policosanol, carnitine, biotin, and acetyl L-Carnitine and anti-oxidants. A composition including one or more cGMP-specific PDE5 inhibitors and/or dopaminergic agonists is administered in the form of a breath-care strip, mint or lozenge, or a food or beverage product. The cGMP-specific PDE5 inhibitor comprises an ingredient selected from the group consisting of sophoflavescenol, vardenafil, tadalafil, and sildenafil. The dopaminergic agonist comprises apomorphine. Vitex agnus-castus extract, and/or one or more of lipoic acid, L-Arginine, folic acid, trimethylglycine, policosanol, carnitine, biotin, and acetyl L-Carnitine may also be included in the delivery vehicle.
Abstract:
Medicament for treating cervical erosion and method for its preparation are provided. The medicament is prepared from five traditional Chinese medicinal materials with the following percent by weight: zedoary oil 10-20, Radix Sophorae Flavescentis 15-30, Cortex Phellodendri 15-30, Radix Gentianae 15-30, alumen 8-15, and borneol 8-15. The said method comprises the steps of: extracting Radix Sophorae Flavescentis, Cortex Phellodendri and Radix Gentianae separately to form 3 sorts of extracts; mixing borneol dissolved in anhydrous ethanol and the admixture obtained by mixing zedoary oil, Tween, and glycerol uniformly to form a mixture; mixing alumen with polyethylene glycol to form another mixture; mixing and homogenizing the above extracts and mixtures thoroughly; and filling the obtained product into suppository mold and then subsequently molding it by cooling to give suppositories.
Abstract:
The present invention relates to a method of use involving the administration of the herbal composition, comprising geranium oil and extracts from roots of the plants of the genus Sophora, to mammalian animals undergoing cancer treatments that would induce the bone marrow suppression side effect, such as chemotherapy and radiation therapy. The composition can take on the form of an oil capsule, tablets, pills, and pastes etc. to be administered orally at specific dosages. The composition can also take on the form of an injection to be administered intravenously and intraperitoneally at specific dosages. The administration can be made before and or after the cancer treatment. In one embodiment, the composition is administered intraperitoneally.